Price
No data yet.
Social Signal Score
Company Profile
- CEO
- Dennis Schulz
- Sector
- Financial Services
- Industry
- Asset Management
- Employees
- 440
- Beta
- 0.97
- Country
- US
Quote
Valuation & Ratios
Returns & Efficiency
Valuation
ITMhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
110Social Signal Score
Mentions (2)
- Newsglobenewswire.com·5h ago·Neutral
Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse MELBOURNE, Australia and INDIANAPOLIS and MUNICH, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE (“ITM”), a global leader in radioisotope production and radiopharmaceutical development.
View source ↗ - Newsreuters.com·7h ago·Positive
Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion Australia's Telix Pharmaceuticals said on Monday it has agreed to acquire Germany-based ITM Isotope Technologies Munich SE for about $1.65 billion on a cash- and debt-free basis.
View source ↗
Congress trades
No disclosed congressional trades in ITM.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
